Skip to main content

Table 2 The logistic analysis of clinicopathological parameters in patients with KIRC

From: CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma

Characteristics

Total (N)

OR (95% CI)

P value

Pathologic T stage (T1 vs. T2 & T3 & T4)

541

0.476 (0.338–0.671)

< 0.001

Pathologic N stage (N1 vs. N0)

258

2.628 (0.8248.378)

0.102

Pathologic M stage (M1 vs. M0)

508

2.427 (1.4574.045)

< 0.001

Primary therapy outcome (CR vs. PD & SD & PR)

147

1.104 (0.4162.927)

0.843

Gender (male vs. female)

541

1.419 (0.9942.026)

0.054

Laterality (right vs. left)

540

0.532 (0.3780.749)

< 0.001

Pathologic stage (Stage I & Stage II vs. Stage III & Stage IV)

538

0.513 (0.3600.730)

< 0.001

Race (White vs. Asian & Black or African American)

534

1.257 (0.7462.118)

0.389

Age (< = 60 vs. > 60)

541

0.950 (0.6781.330)

0.764

Histologic grade (G1 & G2 vs. G3 & G4)

533

0.487 (0.3440.688)

< 0.001

Serum calcium (Low vs. Normal & Elevated)

367

0.742 (0.4911.122)

0.158

Hemoglobin (Low vs. Normal & Elevated)

461

1.428 (0.9852.068)

0.060